Winter and spring flu are surging, and this children's medication can rival oseltamivir

With the increasing temperature difference between day and night, the peak season for children's influenza has arrived. In pediatric clinics and pharmacies, anxious parents are once again facing familiar challenges: how to choose a safe and effective anti flu medication for their children? Having more pharmacy staff with this knowledge can not only improve professional service levels, but also help parents solve problems. Although the efficacy of oseltamivir in combating influenza is evident to all. However, many parents still inevitably worry about the side effects, drug resistance, and medication effectiveness after 48 hours of Western medicine. At this point, we have to mention this children's specific medicine - Qinxiang Qingjie Oral Liquid. As early as 2022, the international SCI journal Translational Pediatrics published a research result on the use of Qinxiang Qingjie Oral Liquid to treat pediatric influenza: in terms of fever reduction and clinical recovery time, Qinxiang Qingjie Oral Liquid is equally effective as oseltamivir in treating pediatric influenza; In terms of symptom improvement, Qinxiang Qingjie Oral Liquid is superior to Oseltamivir. (1) This provides a scientifically validated traditional Chinese medicine plan for the prevention and treatment of influenza in children.

1. Scientific cornerstone: Randomized double-blind trial

Led by Professor Shen Kunling from Beijing Children's Hospital affiliated with Capital Medical University and Professor Ma Rong from the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, this clinical study on the treatment of influenza in children with Qinxiang Qingjie oral solution adopts the internationally recognized "gold standard" design - a randomized, double-blind, double simulated, positive drug parallel controlled multicenter clinical trial, fully ensuring the scientific and reliable results of the research. This study was conducted simultaneously in 15 tertiary hospitals across the country, with half of the patients from traditional Chinese and half from Western hospitals. A total of 231 confirmed cases of influenza were included, and the efficacy and safety of Qinxiang Qingjie Oral Liquid were directly compared with oseltamivir.

II. Efficacy Comparison: Equivalent to Oseltamivir

The core results of the study showed that in terms of the main efficacy indicator - clinical recovery time, the median time of the Qinxiang Qingjie oral solution group and the Oseltamivir group was exactly the same, both being 3 days. This indicates that Qinxiang Qingjie Oral Liquid has reached the same level as mainstream antiviral drugs in promoting the overall recovery of pediatric patients. In addition, both groups showed similar efficacy in multiple secondary indicators: the median duration of fever reduction was 36 hours, and the incidence of complications was at a relatively low level. These consistent data collectively confirm the comprehensive therapeutic value of Qinxiang Qingjie Oral Liquid in inhibiting virus replication and alleviating clinical symptoms.

III. Applicable Scenarios: Addressing the Shortcomings of Western Medicine

1. Dealing with Virus Mutation and Drug Resistance Concerns: Influenza viruses are prone to mutation and may develop resistance to specific antiviral drugs. The advantage of traditional Chinese medicine in treating influenza lies in its "syndrome differentiation and treatment" approach, which focuses on the overall regulation of the "exterior interior heat" syndrome caused by influenza, rather than a single target attack, and may be less susceptible to the influence of viral mutations.

2. Relieve symptoms, make the child more comfortable: Qinxiang Qingjie Oral Liquid has the effects of dispersing wind heat, clearing diarrhea and internal heat, detoxifying and clearing the throat, effectively relieving systemic symptoms such as fever, cough, sore throat, nasal congestion and runny nose caused by influenza, and helping the child to pass the disease more comfortably.

3. Children use Oseltamivir for a wider age range: Oseltamivir is recommended for children aged 1 and above, and for those under 1 year old, it should be evaluated and recommended by a doctor. Use with caution; Qinxiang Qingjie Oral Liquid covers the age group of 6 months to 14 years old, with a wider range of use.

4. An authoritative choice to alleviate medication shortages: When the supply of drugs such as oseltamivir is tight or there are contraindications to use, Qinxiang Qingjie Oral Liquid provides a new and effective solution, avoiding parents' anxiety of having no medication available.

During the flu season, prevention comes first. In addition to vaccination, having a highly validated, effective, and safe anti influenza medication at home is an important part of safeguarding children's health. Qinxiang Qingjie Oral Liquid has become the preferred choice for children's medicine boxes due to its comparable efficacy and good safety to oseltamivir. If a child develops flu symptoms, parents can take medication early under the guidance of a doctor or pharmacist, which can help shorten the course of the illness and alleviate discomfort. As a children's specific traditional Chinese medicine validated by modern science, Qinxiang Qingjie Oral Liquid not only responds to parents' concerns about the side effects of Western medicine, but also to some extent compensates for the limitations of existing antiviral treatments.

Reference:

(1) China's first pediatric specific drug has been published in an international SCI journal for high-quality clinical research on the treatment of influenza. The clinical research results of Qinxiang Qingjie and Zhiyi for the treatment of influenza in children have been published in Translational Pediatrics Chinese Medical Information Guide, September 1, 2022